HOOK: 127% | HOOKIPA Pharma Announces $21.25M Equity Investment from Gilead Sciences
ANNX: 40% | Needham Reiterates Buy on Annexon, Maintains $16 Price Target, B of A Securities Upgrades Annexon to Buy, Raises Price Target to $6
PRZO: 70% | Former Director of Security of the Israeli Defense Establishment Nir Ben Moshe Joining ParaZero